Search

West Pharmaceutical Services Inc

Avatud

SektorTervishoid

396.65 1.74

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

388.61

Max

397.28

Põhinäitajad

By Trading Economics

Sissetulek

15M

154M

Müük

27M

872M

P/E

Sektori keskmine

49.156

49.241

Aktsiakasum

2.37

Dividenditootlus

0.23

Kasumimarginaal

17.654

Töötajad

10,800

EBITDA

6.8M

225M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+5.74% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

0.23%

2.15%

Järgmine tulemuste avaldamine

29. okt 2026

Järgmine dividendimakse kuupäev

18. nov 2026

Järgmine aktsia dividendi kuupäev (ex-date)

11. nov 2026

Turustatistika

By TradingEconomics

Turukapital

2.1B

27B

Eelmine avamishind

394.91

Eelmine sulgemishind

396.65

West Pharmaceutical Services Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. okt 2026, 20:51 UTC

West Pharmaceutical Services Inc is experiencing a decline in after-market trading, now at its lowest point of the day.

23. okt 2026, 19:36 UTC

West Pharmaceutical Services Inc shares fell modestly after earlier gains, remaining below Thursday's close but above the 20-day moving average.

22. okt 2026, 21:02 UTC

West Pharmaceutical Services Inc shares fell in after-market trading, continuing a downward trend that began after Thursday's close.

21. okt 2026, 22:16 UTC

West Pharmaceutical Services Inc shares have shown a slight decline in after-market hours, remaining flat since Wednesday's close and above its 20-day moving average.

20. okt 2026, 23:06 UTC

West Pharmaceutical Services Inc is experiencing a modest decline in after-market trading, having retraced earlier gains since Tuesday's close.

19. okt 2026, 21:51 UTC

West Pharmaceutical Services Inc. is trading modestly higher in after-market hours, marking its highest cumulative return of the day after eight consecutive sessions of gains.

16. okt 2026, 19:36 UTC

West Pharmaceutical Services Inc shares are lower, having declined from Thursday's close and experiencing a notable dip earlier in the session.

15. okt 2026, 23:11 UTC

West Pharmaceutical Services Inc is advancing in after-market trading, showing a modest increase since Thursday's close, continuing a streak of six consecutive higher sessions.

14. okt 2026, 22:01 UTC

West Pharmaceutical Services Inc shares are trading modestly lower in after-market hours, retracing to a session low following four consecutive sessions of gains.

13. okt 2026, 23:16 UTC

West Pharmaceutical Services Inc is trading modestly higher in after-market hours, continuing a trend of upward movement following four consecutive daily increases.

12. okt 2026, 23:56 UTC

West Pharmaceutical Services Inc's shares advanced modestly during after-market hours, with a cumulative return peaking at 0.64% before settling around 0.36%.

9. okt 2026, 22:01 UTC

West Pharmaceutical Services Inc is trading higher in after-market hours, showing a significant recovery from earlier losses since Friday's close.

8. okt 2026, 20:07 UTC

West Pharmaceutical Services Inc shares are modestly lower, marking the fourth consecutive day of declines amid significant broader market downward pressure.

6. okt 2026, 20:02 UTC

West Pharmaceutical Services Inc shares fell modestly, dipping below Monday's close after an early high but remaining above the 20-day moving average.

5. okt 2026, 20:01 UTC

News

West Pharmaceutical Services Inc. is participating in CPHI Worldwide in Milan to showcase its drug packaging solutions, with shares trading higher amid recent gains.

2. okt 2026, 22:01 UTC

Modestly higher in after-market, nearing one-month trading range high.

1. okt 2026, 23:01 UTC

West Pharmaceutical Services Inc is trading modestly higher in after-market hours, remaining well above its 20-day moving average and near the upper end of its one-month trading range.

30. sept 2026, 19:46 UTC

West Pharmaceutical Services Inc is trading lower, reaching its lowest point of the day, despite remaining above its 20-day moving average.

29. sept 2026, 22:01 UTC

West Pharmaceutical Services Inc experienced a modest decline in after-market trading, retracing from earlier gains to its lowest point of the day.

28. sept 2026, 20:07 UTC

West Pharmaceutical Services Inc is up in the current session, recovering from an early dip and settling above Friday's close while near its one-month trading range high.

25. sept 2026, 20:07 UTC

West Pharmaceutical Services Inc shares fell modestly as the broader market declines, despite remaining above its 20-day moving average and near the upper end of its one-month range.

24. sept 2026, 22:40 UTC

West Pharmaceutical Services Inc declined in after-hours trading, reversing an initial gain, despite remaining above its 20-day moving average.

23. sept 2026, 23:51 UTC

West Pharmaceutical Services Inc is seeing a modest decline in after-market trading, positioned at the lower end of today's range but above its 20-day moving average.

22. sept 2026, 20:02 UTC

News

Morgan Stanley upgraded West Pharmaceutical Services Inc to Overweight and raised its price target to $400, contributing to a significant rise in the stock.

18. sept 2026, 20:03 UTC

West Pharmaceutical Services Inc shares fell sharply, reversing from an earlier peak to drop to their lowest point late in the morning amid a broader decline.

17. sept 2026, 22:41 UTC

West Pharmaceutical Services Inc is experiencing a modest decline in after-market trading, moving lower alongside the broader market's significant downward movement.

16. sept 2026, 20:13 UTC

West Pharmaceutical Services Inc is advancing in after-market trading, significantly above its 20-day moving average since Wednesday's close.

15. sept 2026, 20:13 UTC

West Pharmaceutical Services shares are lower in after-market hours amid negative market sentiment and concerns over economic momentum and potential interest rate hikes.

14. sept 2026, 20:07 UTC

News

West Pharmaceutical Services is gaining as CFO discusses strong second-quarter results at the Morgan Stanley conference, despite a recent cyber incident.

11. sept 2026, 20:01 UTC

News

UBS raised West Pharmaceutical Services' price target to $415, maintaining a "buy" rating. Shares are higher since Thursday's close despite earlier session declines.

Võrdlus sarnastega

Hinnamuutus

West Pharmaceutical Services Inc Prognoos

Hinnasiht

By TipRanks

5.74% tõus

12 kuu keskmine prognoos

Keskmine 417.4 USD  5.74%

Kõrge 440 USD

Madal 400 USD

Põhineb 5 Wall Streeti analüütiku instrumendi West Pharmaceutical Services Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

5 ratings

5

Osta

0

Hoia

0

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat